Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliott D Crouser

Showing results (11-20 of 76) with videos related to

Pageof 8
Sort By:
Frontiers in Immunology|August 28, 2020
Current Sarcoidosis Models and the Importance of Focusing on the GranulomaLandon W Locke, Larry S Schlesinger, Elliott D Crouser
Seminars in Respiratory and Critical Care Medicine|October 23, 2025
Genetics and Social Determinants of Health as Drivers of Epidemiologic Variation in SarcoidosisJohn Odackal, Elliott D Crouser, Michelle Sharp, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 30, 2016
Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosisElliott D Crouser, Emily Ruden, Mark W Julian, et al.
Journal of the American College of Emergency Physicians Open|March 14, 2025
Diagnostic Performance of Monocyte Distribution Width for the Detection of Sepsis: A Systematic Review and Meta-AnalysisGregory J Eisinger, Quinn Hosler, Elliott D Crouser, et al.
Plos One|June 4, 2011
An in silico modeling approach to understanding the dynamics of sarcoidosisBaltazar D Aguda, Clay B Marsh, Michael Thacker, et al.
Annals of the American Thoracic Society|October 20, 2017
Executive Summary of the NHLBI Workshop Report: Leveraging Current Scientific Advancements to Understand Sarcoidosis Variability and Improve OutcomesLisa A Maier, Elliott D Crouser, William J Martin, et al.
Contemporary Clinical Trials Communications|October 22, 2020
Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosisErinn M Hade, Rachel M Smith, Daniel A Culver, et al.
Chest|February 11, 2004
Toxicity of Food Drug and Cosmetic Blue No. 1 dye in critically ill patientsMaria R Lucarelli, Mary Beth Shirk, Mark W Julian, et al.
Critical Care Medicine|March 13, 2002
Endotoxin-induced mitochondrial damage correlates with impaired respiratory activityElliott D Crouser, Mark W Julian, Dorottya V Blaho, et al.
Critical Care Medicine|June 23, 2006
Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsisElliott D Crouser, Mark W Julian, Jennifer E Huff, et al.
Pageof 8

Showing results (11-20 of 76) with videos related to

Sort By:
Pageof 8
Frontiers in Immunology|August 28, 2020
Current Sarcoidosis Models and the Importance of Focusing on the GranulomaLandon W Locke, Larry S Schlesinger, Elliott D Crouser
Seminars in Respiratory and Critical Care Medicine|October 23, 2025
Genetics and Social Determinants of Health as Drivers of Epidemiologic Variation in SarcoidosisJohn Odackal, Elliott D Crouser, Michelle Sharp, et al.
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|June 30, 2016
Resolution of abnormal cardiac MRI T2 signal following immune suppression for cardiac sarcoidosisElliott D Crouser, Emily Ruden, Mark W Julian, et al.
Journal of the American College of Emergency Physicians Open|March 14, 2025
Diagnostic Performance of Monocyte Distribution Width for the Detection of Sepsis: A Systematic Review and Meta-AnalysisGregory J Eisinger, Quinn Hosler, Elliott D Crouser, et al.
Plos One|June 4, 2011
An in silico modeling approach to understanding the dynamics of sarcoidosisBaltazar D Aguda, Clay B Marsh, Michael Thacker, et al.
Annals of the American Thoracic Society|October 20, 2017
Executive Summary of the NHLBI Workshop Report: Leveraging Current Scientific Advancements to Understand Sarcoidosis Variability and Improve OutcomesLisa A Maier, Elliott D Crouser, William J Martin, et al.
Contemporary Clinical Trials Communications|October 22, 2020
Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosisErinn M Hade, Rachel M Smith, Daniel A Culver, et al.
Chest|February 11, 2004
Toxicity of Food Drug and Cosmetic Blue No. 1 dye in critically ill patientsMaria R Lucarelli, Mary Beth Shirk, Mark W Julian, et al.
Critical Care Medicine|March 13, 2002
Endotoxin-induced mitochondrial damage correlates with impaired respiratory activityElliott D Crouser, Mark W Julian, Dorottya V Blaho, et al.
Critical Care Medicine|June 23, 2006
Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsisElliott D Crouser, Mark W Julian, Jennifer E Huff, et al.
Pageof 8